XO Life
Latest round
- Seed
Last raised
- Feb 2022
Total raised
- $2.3M
Investors
- 3
About XO Life
Based in Munich, Germany, and founded in 2018 by CEO Friderike Bruchmann, XO Life GmbH is a MedTech company that connects patients and pharma manufacturers to better understand patients. XO Life provides the impact monitor, a real-world evidence platform that allows patients to answer questions related to their therapies, medicines, and health conditions and generates data-driven insights on drug effectiveness and safety profiles. The company also provides digital pharmacovigilance, a digital end-to-end software-as-a-service solution to pharma companies for drug safety data intake, communication, and evaluation.
Who invested in XO Life
3 investors across 1 round
See all investors in XO Life
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 16, 2022
Amount
$2.3M
Investors
Questions about XO Life
Who invested in XO Life?
XO Life has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has XO Life raised?
XO Life has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did XO Life last raise money?
XO Life's most recent round on record is a Seed, in Feb 2022.
What does XO Life do?
Based in Munich, Germany, and founded in 2018 by CEO Friderike Bruchmann, XO Life GmbH is a MedTech company that connects patients and pharma manufacturers to better understand patients.
Where is XO Life headquartered?
XO Life is headquartered in Munich, Germany.
Which VCs invest in companies like XO Life?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back healthcare it companies at XO Life's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like XO Life? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.